MeSH Browser

MeSH Supplementary: MDACC protocol
Unique ID: C072754
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C072754
Entry Term(s): M.D. Anderson Cancer Center protocol
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Hydrocortisone; Methotrexate
Frequency: 1
Note: protocol of alternating high doses of cyclophosphamide & methotrexate, with cytarabine & hydrocortisone coordinated with the methotrexate; used for Burkitt's lymphoma and advanced nonlymphoblastic lymphoma in children
Source: Am J Pediatr Hematol Oncol 1991 Fall;13(3):288-95
Date of Entry: 1992/03/10
Revision Date: 2000/11/30

MDACC protocol MeSH Supplementary Concept Data 2024